Showing results (1531-1540 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|February 8, 2021
Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic AdenocarcinomaGehan Botrus, Heidi Kosirorek, Mohamad Bassam Sonbol, et al.The Oncologist|February 9, 2021
Effects of Ado-Trastuzumab Emtansine and Fam-Trastuzumab Deruxtecan on Metastatic Breast Cancer Harboring HER2 Amplification and the L755S MutationToru Mukohara, Ako Hosono, Sachiyo Mimaki, et al.The Oncologist|February 5, 2021
College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal CancerHai-Yang Chen, Li-Li Feng, Ming Li, et al.The Oncologist|February 17, 2021
Metastatic Myxofibrosarcoma with Durable Response to Temozolomide Followed by Atezolizumab: A Case ReportJason P Lambden, Max F Kelsten, Brian C Schulte, et al.The Oncologist|February 17, 2021
A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 StudyJohn M Varlotto, Zhuoxin Sun, Bonnie Ky, et al.The Oncologist|February 22, 2017
Using Metaphors to Explain Molecular Testing to Cancer PatientsAna P M Pinheiro, Rachel H Pocock, Margie D Dixon, et al.The Oncologist|March 10, 2017
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal CancerRocío García-Carbonero, Eric van Cutsem, Fernando Rivera, et al.The Oncologist|February 8, 2017
Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid TumorsMaikel Verduin, Jaap D Zindler, Hanneke M A Martinussen, et al.The Oncologist|February 8, 2017
Pharmacoepidemiology of Clinically Relevant Hypothyroidism and Hypertension from Sunitinib and SorafenibChristine M Walko, Ronald E Aubert, Ninh M La-Beck, et al.The Oncologist|February 8, 2017
An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation-Negative Pancreatic Ductal AdenocarcinomaYoko Shimada, Takashi Kohno, Hideki Ueno, et al.Pageof 571